Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
7.68
-0.02 (-0.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Health Catalyst Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 11.5, with a low estimate of 7.00 and a high estimate of 16. The average target predicts an increase of 49.74% from the current stock price of 7.68.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCAT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 3 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +30.21% | Oct 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +108.33% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +108.33% | Sep 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $10 → $13 | Buy | Maintains | $10 → $13 | +69.27% | Sep 4, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +43.23% | Aug 26, 2024 |
Financial Forecast
Revenue This Year
313.64M
from 295.94M
Increased by 5.98%
Revenue Next Year
349.45M
from 313.64M
Increased by 11.42%
EPS This Year
0.37
from -2.09
EPS Next Year
0.49
from 0.37
Increased by 32.20%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 324.5M | 364.4M | 408.9M |
| Avg | 313.6M | 349.5M | 389.5M |
| Low | 300.7M | 330.9M | 359.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 9.6% | 16.2% | 17.0% |
| Avg | 6.0% | 11.4% | 11.5% |
| Low | 1.6% | 5.5% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.54 | 0.76 | 0.99 |
| Avg | 0.37 | 0.49 | 0.70 |
| Low | 0.26 | 0.29 | 0.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 104.7% | 102.4% |
| Avg | - | 32.2% | 42.6% |
| Low | - | -20.7% | -0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.